ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "immunology"

  • Abstract Number: 1736 • ACR Convergence 2022

    IL-23 Signaling Induces Autoimmune Disease Genes in Mucosal-Associated Invariant T Cells

    Tharshana Stephen1, Ambre Dangien1, Claire Leloup1, Ikram Mezghiche1, Laetitia Camard1, Hanan Yahia-Cherbal1, Vincent Guillemot2, Natalia Pietrosemoli1, Hélène Lopez-Maestre1, Julie Marsande1, Milena Hasan1, Dan Cua3, Anne Fourie4, Carrie Greving5, Raphaelle Parker6, Barbara Joyce Shaikh7, Bénédicte Oulès8, Sarah Guégan8, Sélim Aractingi8, Elisabetta Bianchi1 and Lars Rogge1, 1Institut Pasteur, Paris, France, 2Institut Pasteur, Paris, Ile-de-France, France, 3Janssen Research and Development, LLC, Spring House, PA, 4Janssen Research & Development, LLC, San Diego, CA, USA, San Diego, CA, 5Janssen Research & Development, LLC, San Diego, CA, USA, San Diego, 6Janssen Research & Development, Janssen-Cilag, Paris, France, 7Janssen Research & Development, LLC, San Diego, CA, 8Hôpital Cochin, AP-HP, Paris, France

    Background/Purpose: Genome-wide association studies and mouse models of autoimmune disease have demonstrated an important role of the IL-23 signaling pathway in the pathogenesis of axial…
  • Abstract Number: 2185 • ACR Convergence 2022

    Development of a Novel Regulatory T Cell-Based Therapy for Patients with Rheumatoid Arthritis

    Anne-Renee van der Vuurst de Vries1, Kathryn Hooper1, Jonathan Graf2, Katie Tuckwell1 and Joshua Beilke1, 1Sonoma Biotherapeutics, South San Francisco, CA, 2Ucsf, San Francisco, CA

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory condition with persistent unmet medical need despite significant treatment advances. The pathogenesis of RA is initiated…
  • Abstract Number: 0261 • ACR Convergence 2022

    Machine Learning and Computational Pathology Can Reveal Synovial Pathotypes in Mice and Humans

    Richard Bell1, Matthew Brendel2, Justin Xiang3, AMP RA/SLE Consortium1, Edward DiCarlo1, Jennifer Anolik4, Laura Donlin1, Dana Orange5, Edward Schwarz4, Lionel Ivashkiv1 and Fei Wang2, 1Hospital for Special Surgery, New York, NY, 2Weil Cornell Medical College, New York, NY, 3Horace Grant High School, New York, NY, 4University of Rochester Medical Center, Rochester, NY, 5The Rockefeller University, New York, NY

    Background/Purpose: Synovial pathotyping is a critical step in understanding the etiology of inflammatory arthritis as different pathotypes have differential response to therapy. Determining these pathotypes…
  • Abstract Number: 0646 • ACR Convergence 2022

    Modulation of Type I IFN Production and Regulatory T Cells by the PKGI/ROCK Signaling Pathway

    Ruth Fernandez Ruiz1, Ilona Nln2, Jacqueline Paredes2 and Timothy Niewold2, 1Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 2Hospital for Special Surgery, New York, NY

    Background/Purpose: IFNα is a pathogenic factor in SLE. The PRKG1 rs7897633 variant has been previously identified as the top hit in European ancestry patients with…
  • Abstract Number: 0791 • ACR Convergence 2022

    Immunogenicity and Safety of a Three-dose SARS-CoV-2 Vaccination Strategy in Patients with Immune-mediated Inflammatory Diseases on Immunosuppressive Therapy

    Ingrid Jyssum1, Anne Therese Tveter1, Joe Sexton1, Ingrid Egeland Christensen1, Siri Mjaaland2, David Warren3, Tore K. kvien1, Kristin Hammersbøen Bjørlykke4, Grete Birkeland Kro3, Jørgen Jahnsen4, Ludvig A. Munthe3, Espen Haavardsholm1, Gunnveig Grødeland3, Sella Aarrestad Provan1, Kristin Kaasen Jørgensen4, Guro Goll1 and Silje Watterdal Syversen1, 1Diakonhjemmet Hospital, OSLO, Norway, 2Norwegian Institute of Public Health, Oslo, Norway, 3Oslo University Hospital, Oslo, Norway, 4Akershus University Hospital, Oslo, Norway

    Background/Purpose: Humoral vaccine responses to SARS-Cov-2 vaccines are impaired and short lasting in patients with immune-mediated inflammatory diseases (IMIDs). Concerns have been raised regarding their…
  • Abstract Number: 1565 • ACR Convergence 2022

    Dissection of Ocular and Peripheral Blood Immune Phenotypes Suggests Preferential Transmigration of CD16+ Monocytes to Effector Sites in Behçet’s Disease

    Yesim Ozguler1, Ziyan Lin2, Ann Cavers3, gulen Hatemi4, Olivier Manches5 and Johannes Nowatzky3, 1Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, New York, NY, 2NYU Grossman School of Medicine, NYU Langone Applied Informatics Laboratories, New York, NY, 3NYU Grossman School of Medicine, New York, NY, 4Istanbul University-Cerrahpaşa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 5Recherche et Développement, Immunobiology and Immunotherapy in Chronic Diseases, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France

    Background/Purpose: Cellular immunity of Behçet's Disease (BD) remains poorly understood. Previous work has provided clues pointing to most innate and adaptive immune cell types in…
  • Abstract Number: 1742 • ACR Convergence 2022

    Shared Epitope Allomorphs Directly Influence Antigen-specific T-cell Responses in RA

    Ravi Kumar1, Anatoly Dubnovitsky1, Christina Gerstner1, Niyaz Yoosuf2, Sara Turcinov1, Sanjay Boddul1, Fredrik Wermeling1, Lars Klareskog1, Leonid Padyukov1 and vivianne malmström1, 1Karolinska Institutet, Stockholm, Sweden, 2Bioinvent International AB, Lund, Sweden

    Background/Purpose: The products of rheumatoid arthritis (RA)-associated MHC class II risk alleles HLA-DRB1*04:01 and *04:04 (DR4) differ only by two amino acids in the peptide…
  • Abstract Number: 2186 • ACR Convergence 2022

    Cellular and Humoral Responses Following SARS-CoV-2 mRNA Vaccination in Patients on PD-1 Immunotherapy with irAEs

    Sokratis Apostolidis1, Paulina Coutifaris2, Mark Painter3, Ajinkya Pattekar2, Rishi Goel1, divij mathew2, Wenzhao Meng2, Kevin Wang2, Bria Fulmer2, Angela Corrigan2, Kendall Lundgreen2, Elizabeth Drapeau2, Derek Oldridge2, Josephine Giles2, Amy Baxter2, Sasikanth Manne2, Michelle Mckeague2, Ahron Flowers2, Oliva Kuthuru2, Sherea Long2, Jeanette Dougherty2, Sigrid Gouma2, Justine Williams2, Maura McLaughlin2, Sharon Adamski2, Alba Grifoni4, Daniela Weiskopf4, Alessandro Sette4, Scott Hensley2, Paul Bates2, Eline Luning Prak1, Laura Vella2, Giorgos Karakousis2, Ravi Amaravadi2, Suzanne McGettigan2, Kristin Kreider2, Tara Mitchell2, Allison Greenplate2, Lynn Schuchter2, Alexander Huang2 and E. John Wherry1, 1University of Pennsylvania, Philadelphia, PA, 2UPenn, Philadelphia, 3UPenn, Philadelphia, PA, 4LJI, La Jolla

    Background/Purpose: Patients with cancer exhibit increased mortality from SARS-CoV-2 infection compared to the general population. SARS-CoV-2 mRNA vaccination in healthy individuals generates effective and long-lasting…
  • Abstract Number: 0300 • ACR Convergence 2022

    Exposure-Response Analyses of Upadacitinib Effects on Plasma Biomarkers in Rheumatoid Arthritis Patients

    Yuli Qian1, Fang Cai2, Thierry Sornasse3, Jie Shen1, Heidi Camp4 and Mohamed-Eslam Mohamed1, 1AbbVie, Inc., North Chicago, IL, 2AbbVie, Redwood City, CA, 3AbbVie, South San Francisco, CA, 4Abbvie, Winnetka, IL

    Background/Purpose: Upadacitinib (UPA) is an oral Janus kinase (JAK) inhibitor approved for the treatment of moderately-to-severely active rheumatoid arthritis (RA). Previous investigations demonstrated UPA modulates…
  • Abstract Number: 0648 • ACR Convergence 2022

    Pathogenic Anti-C1q Antibodies Potentiate Activation of the Classical Complement Pathway in a Subset of Lupus Nephritis Patients

    Edmund Chang1, Julian Low2, Ellen Cahir-McFarland2, Henk-Andre Kroon2, Yaisa Andrews-Zwilling2, Ted Yednock2 and Ann Mongan2, 1Annexon Biosciences, Brisbane, CA, 2Annexon Biosciences, South San Francisco, CA

    Background/Purpose: In LN, excess immune complexes lead to nephrotic deposition of C1q and C4d, the latter of which has been correlated with circulating C4d and…
  • Abstract Number: 0806 • ACR Convergence 2022

    Long-term Effectiveness of Sublingual Polybacterial Vaccines in Patients with Systemic Autoimmune Disease and Active Pharmacological Immunosuppression

    Inés Pérez Sancristóbal1, María Paula Álvarez Hernández2, Silvia Sanchez - Ramon3, Cristina Martinez4, Eduardo de la Fuente3, Concepcion Morado4, Dalifer Freites Nuñez2, Benjamin Fernandez Gutierrez5 and Gloria Candelas4, 1Instituto de Investigación Sanitaria San Carlos, Rheumatology, Madrid, Spain, 2Hospital Clínico San Carlos, Madrid, Spain, 3Department of Clinical Immunology, IML and IdSSC, Hospital Clínico San Carlos, Madrid, Spain, 4Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, 5Hospital Clínico San Carlos, Rheumatology Deparment, Madrid, Spain

    Background/Purpose: Infections in patients with systemic autoimmune disease (SAD) are associated with immune dysfunction, disease activity and immunosuppression. Synthetic and biologic disease-modifying drugs (DMARDs) have…
  • Abstract Number: 1570 • ACR Convergence 2022

    Memory CD4+T Cell Signature Is Associated with Unfavorable Prognosis in IgG4-related Disease: Risk Stratification by Machine-learning

    Yuxue Nie1, zheng liu1, Wei Cao2, Taisheng Li2 and Wen Zhang3, 1Department of Rheumatology, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 2Department of Infectious Diseases, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 3Peking Union Medical College Hospital, Beijing, China

    Background/Purpose: IgG4-related disease (IgG4-RD) is a chronic immune-mediated disease with significant heterogeneity. A better understanding of the variance in the immune signature of IgG4-RD will…
  • Abstract Number: 1743 • ACR Convergence 2022

    Identification of Immune Cell Types in the Peripheral Blood of Rheumatoid Arthritis Patients Associated with Susceptibility and Response to Treatment

    Maria Christofi1, Ben Mulhearn2, Lysette Marshall1, Megan Sutcliffe1, Darren Plant1, Kimme Hyrich1, Ann Morgan3, Anthony Wilson4, John D Isaacs5, Soumya Raychaudhuri6, Anne Barton1 and Sebastien Viatte1, 1The University of Manchester, Manchester, United Kingdom, 2Royal United Hospital Bath | University of Bath, Bath, United Kingdom, 3University of Leeds, Leeds, United Kingdom, 4University College Dublin, Dublin, Ireland, 5Institute for Translational and Clinical Research, Newcastle University and Musculoskeletal Unit, Newcastle upon Tyne Hospitals, Newcastle upon Tyne, United Kingdom, 6Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Rheumatoid arthritis (RA) is a complex immune mediated disease that affects 1% of the population. Even with modern therapeutic strategies, many patients with RA…
  • Abstract Number: 2195 • ACR Convergence 2022

    Pre-exposure Prophylaxis for SARS-CoV-2 with Subcutaneous Casirivimab/Imdevimab in Vaccine-refractory Patients with Immune-mediated Inflammatory Diseases

    Filippo Fagni1, Katja Schmidt2, Daniela Bohr3, Larissa Valor Mendez4, Ioanna Minopoulou2, Melek Yalcin Mutlu2, Fabian Hartmann2, Koray Tascilar4, Karin Manger5, Bernhard Manger2, Arnd Kleyer4, David Simon4, Georg Schett6 and Thomas Harrer2, 1University Hospital Erlangen; Department of Internal Medicine 3 - Rheumatology and Immunology, Erlangen, Germany, 2University Hospital Erlangen, Department of Internal Medicine 3 - Rheumatology and Immunology, Erlangen, Germany, 3Department of Internal Medicine 3, Rheumatology & Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nurnberg and University Hospital Erlangen, Erlangen, Germany, 4Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-UniversityErlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 5Rheumatology Practice Bamberg, Bamberg, Germany, 6Universitätsklinikum Erlangen, Erlangen, Germany

    Background/Purpose: Humoral responses to SARS-CoV-2 vaccination are reduced in patients with immune-mediated inflammatory diseases (IMID), especially when treated with B-cell depletion therapies, leading to increased…
  • Abstract Number: 0342 • ACR Convergence 2022

    Multi-Parametric Interrogation of the Systemic Lupus Erythematosus (SLE) Immunome Reveals Multiple Derangements

    Katherine Nay Yaung1, Joo Guan Yeo2, Hui Nee Annie Law3, Martin Wasser4, Thaschawee Arkachaisri5, Julian Thumboo3, Andrea Low3 and Salvatore Albani4, 1Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore; Duke-NUS Medical School, Singapore, Singapore, 2KK Hospital, Singapore; Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore, 3Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore, 4Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore, Singapore, 5KK Women's and Children's Hospital, SingHealth, Singapore, Singapore

    Background/Purpose: Systemic lupus erythematosus (SLE) is a complex, systemic autoimmune disease that interferes with the balance between regulation and immunity, resulting in immune system dysfunction.…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 33
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology